Search Results - "Wang, Michael W."
-
1
RANKL Employs Distinct Binding Modes to Engage RANK and the Osteoprotegerin Decoy Receptor
Published in Structure (London) (07-11-2012)“…Osteoprotegerin (OPG) and receptor activator of nuclear factor κB (RANK) are members of the tumor necrosis factor receptor (TNFR) superfamily that regulate…”
Get full text
Journal Article -
2
Examining a punishment-related brain circuit with miniature fluorescence microscopes and deep learning
Published in Addiction neuroscience (01-06-2024)“…In humans experiencing substance use disorder (SUD), abstinence from drug use is often motivated by a desire to avoid some undesirable consequence of further…”
Get full text
Journal Article -
3
Minibox: Custom solo or semi-group housing chambers for long term housing of rats with miniscopes
Published in MethodsX (01-12-2024)“…In this detailed procedure, we include open-source methodologies using ‘solidworks’ designs for creating solo or semi-group housing units for rats wearing…”
Get full text
Journal Article -
4
The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling
Published in The Journal of clinical investigation (15-07-2004)“…Highly active antiretroviral therapy (HAART), which includes HIV protease inhibitors (PIs), has been associated with bone demineralization. To determine if…”
Get full text
Journal Article -
5
Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma
Published in Journal of neuro-oncology (01-04-2017)“…Latino Americans are a rapidly growing ethnic group in the United States but studies of glioblastoma in this population are limited. We have evaluated…”
Get full text
Journal Article -
6
Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling
Published in The Journal of biological chemistry (22-02-2002)“…To define the molecular mechanism(s) by which interleukin (IL)-4 reversibly inhibits formation of osteoclasts (OCs) from bone marrow macrophages (BMMs), we…”
Get full text
Journal Article -
7
Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats
Published in Experimental and molecular pathology (01-08-2017)“…Commercial targeted genomic profiling with next generation sequencing using formalin-fixed paraffin embedded (FFPE) tissue has recently entered into clinical…”
Get full text
Journal Article -
8
Receptor Activator of Nuclear Factor-κB Ligand Activates Nuclear Factor-κB in Osteoclast Precursors
Published in Endocrinology (Philadelphia) (01-03-2001)“…Abstract Receptor activator of nuclear factor-κB ligand [RANK ligand (RANK-L)] stimulates mature osteoclasts to resorb bone, a process associated with NF-κB…”
Get full text
Journal Article -
9
The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling
Published in The Journal of clinical investigation (15-07-2004)“…Highly active antiretroviral therapy (HAART), which includes HIV protease inhibitors (PIs), has been associated with bone demineralization. To determine if…”
Get full text
Journal Article -
10
T Cell Repertoire Diversity Is Decreased in Type 1 Diabetes Patients
Published in 基因组蛋白质组与生物信息学报:英文版 (2016)“…Type 1 diabetes mellitus (T1D) is an immune-mediated disease. The autoreactive T cells in T1D patients attack and destroy their own pancreatic cells. In order…”
Get full text
Journal Article -
11
Receptor Activator of Nuclear Factor-κB Ligand Activates Nuclear Factor-κB in Osteoclast Precursors1
Published in Endocrinology (Philadelphia) (01-03-2001)“…Receptor activator of nuclear factor-κB ligand [RANK ligand (RANK-L)] stimulates mature osteoclasts to resorb bone, a process associated with NF-κB activation…”
Get full text
Journal Article -
12
Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling
Published in The Journal of biological chemistry (22-02-2002)“…To define the molecular mechanism(s) by which interleukin (IL)-4 reversibly inhibits formation of osteoclasts (OCs) from bone marrow macrophages (BMMs), we…”
Get full text
Journal Article